期刊文献+

醋酸钙联合高通量透析治疗尿毒症患者高磷血症的疗效分析 被引量:8

下载PDF
导出
摘要 目的探讨醋酸钙联合高通量透析对尿毒症患者高磷血症的疗效。方法将52例维持性血液透析(MHD)患者分为观察组和对照组,各26例。两组入组前均行低通量透析≥12个月。入组后对照组改用高通量透析联合碳酸钙口服,观察组给予高通量透析联合醋酸钙口服治疗。测定两组入组时,治疗2、4个月个月时血钙(Ca)、血磷(P)、全段甲状旁腺激素水平(i PTH)水平,并评价两组皮肤瘙痒程度。结果治疗2个月,两组患者Ca水平均较入组时高(均<0.05),P、i PTH均较入组时低(均<0.05);治疗4个月,两组血P、i PTH下降更为明显。观察组治疗2、4个月P及i PTH均低于对照组(均<0.05),对照组血Ca水平高于观察组(<0.05)。两组经治疗后皮肤瘙痒程度评分均呈下降趋势(均<0.05),两组间差异无统计学意义(>0.05)。对照组高钙血症发生率较高于观察组,但差异无统计学意义(>0.05)。结论醋酸钙联合高通量透析对MHD患者的高磷血症疗效确切,皮肤瘙痒显著改善,并在一定程度上减少高钙血症的发生。
作者 朱欢扬
机构地区 永嘉县人民医院
出处 《现代实用医学》 2015年第4期497-498,551,共3页 Modern Practical Medicine
  • 相关文献

参考文献8

二级参考文献105

  • 1杨国刚.慢性肾功能衰竭患者高磷血症研究及治疗进展[J].吉林医药学院学报,2010,31(2):102-105. 被引量:13
  • 2王笑云,谭若芸.慢性肾脏病(CKD)继发性甲状旁腺功能亢进的近代治疗[J].中国血液净化,2005,4(1):1-4. 被引量:20
  • 3赵学智,吴俊,徐成钢,孙琳琳,吉程程,梅长林.慢性肾衰竭血清甲状旁腺素与肾小球滤过率的相关性探讨[J].中国中西医结合肾病杂志,2005,6(5):278-279. 被引量:5
  • 4Pisoni RL, Wikstrom B, Elder SJ,et al. Pruritus in haemodialysispatients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)[J]. Nephrol Dial Transplant,2006,21 (12): 3495-3505.
  • 5Narita I, Iguchi S, Omori K, et al. Uremic pruritus in chronic hemodialysis patients[J],J Nephrol,2008,21 (2): 161 - 165.
  • 6Keithi-Reddy SR, Patel TV, Armstrong AW, et al. Uremic pruritus [J]. Kidney Int,2007,72(3):373-377.
  • 7Wikstrfim B. Itchy skin-a clinical problem for haemodialysis patients[J]. Nephrol Dial Transplant,2007,22 (Suppl 5 ) :v3-v7.
  • 8Canand B, Bragg-Gresham JL, Marshall MR, et al.Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS[J]. Kidney Int,2006,69(11):2087-2093.
  • 9Stefoni S, Cianciolo G, Coli L, et al.Artificial kidney: status of the art and new perspectives[J]. Artif Cells Blood Substit Immobil Biotechnol, 2003,31(2):111-112.
  • 10Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med,1994,331:1338-1342.

共引文献103

同被引文献77

  • 1庄乙君,覃学,高海娥.不同透析方式治疗尿毒症皮肤瘙痒的疗效比较及对血清甲状旁腺素、β2微球蛋白水平的影响[J].中国老年学杂志,2014,34(4):934-936. 被引量:36
  • 2王质刚.血液净化学[M].3版.北京:北京科学技术出版社,2010:357-360.
  • 3Palmer SC, Hayen A, Macaskill P, et al. Scrum levels of phosphorus, parathyroid Hommone, and calcium and risks Of death and cardiovascular disease in individuals With chronic kidney disease:asystematic review and meta-analysis[J], JAMA,2011,305(11):1119-1127.
  • 4Schneider A, Drechsler C, Krane V, et al. The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS studyl[J]. Clin J Am Society Nephrol,2012,7(1) :52-59.
  • 5Bosch JP, Lew SQ, Barlee V, et al. Clinical use of high-ef- ficiency hemodialysis treatments: LongTterm assessment [J]. Hemodial Int, 2006,10(1) : 73-81.
  • 6Davenpoort A,Gardner C,Delaney M, et al. The effect of dialysis modality on phosphate control: haemodialysis compared to haemodiafiltration-The Pan Thames Renal Audit[J]. Nephrol Dial Transplant, 2010, 25 (3):897- 901.
  • 7李岩.碳酸司维拉姆与醋酸钙对尿毒症患者高磷血症对照研究[J].医学信息,2015,28(36):89-90.
  • 8Naves Diaz M,Passlick Deetjen J,Guinsburg A,et al.Calcium,phosphorus,PTH and death rates in a large sample of dialysis patients from Latin America.The CORES Study[J].Nephrology,dialysis,transplantation:official publication of the European Dialysis and Transplant Association-European Renal Association,2011,26(6):1938-1947.
  • 9Orasan RA,Patiu IM,Anghel D,et al.Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration[J].International Urology and Nephrology,2013,45(5):1415-1422.
  • 10陶一鸣,梁馨苓,王文健,刘双信,夏运风,李志莲,史伟.醋酸钙联合生理钙透析治疗维持性血液透析患者高磷血症的疗效观察[J].实用医学杂志,2011,27(22):4008-4009. 被引量:17

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部